Prevalence of non-syndromic orofacial clefts: based on 15,094,978 Chinese perinatal infants by Fan, D et al.
Oncotarget13981www.impactjournals.com/oncotarget
www.impactjournals.com/oncotarget/              Oncotarget, 2018, Vol. 9, (No. 17), pp: 13981-13990
Prevalence of non-syndromic orofacial clefts: based on 
15,094,978 Chinese perinatal infants
Dazhi Fan1,2, Shuzhen Wu1,2, Li Liu3,5, Qing Xia3,6, Guo Tian5, Wen Wang2, Shaoxin 
Ye1,2, Lijuan Wang2, Jiaming Rao1,7, Xiao Yang3,8, Zhen Yu9, Lihong Xin10, Song Li11, 
Zhenghua Duan12, Tianchen Zhang13, Song Wu4, Xiaoling Guo1,2 and Zhengping 
Liu1,2
 1 Foshan Institute of Fetal Medicine, Southern Medical University Affiliated Maternal and Child Health Hospital of Foshan, 
Foshan, Guangdong, 528000, China
 2 Department of Obstetrics, Southern Medical University Affiliated Maternal and Child Health Hospital of Foshan, Foshan, 
Guangdong, 528000, China
 3 Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, 230032, 
China
 4School of Integrated Traditional and Western Medicine, Anhui University of Chinese Medicine, Hefei, Anhui, 230038, China
 5 Department of Library, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, 
China
 6Menzies Institute for Medical Research, University of Tasmania, Private Bag 23, Hobart, Tasmania 7000, Australia
 7Department of Epidemiology, Medical College of Jinan University, Guangzhou, Guangdong, 510632, China
 8Changzhou Center for Disease Control and Prevention, Changzhou, Jiangsu, 213003, China
 9 Department of Maternal, Child and Adolescent Health, School of Public Health, Anhui Medical University, Hefei, Anhui, 
230032, China
10 Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China
11Chaohu Hospital Affiliated Anhui Medical University, Chaohu, Anhui, 238000, China
12Chengdu Center for Disease Control and Prevention, Chengdu, Sichuan, 610041, China
13 Department of Communicable Diseases Control, Jiangxi Provincial Center for Disease Control and Prevention, Nanchang 
330000, Jiangxi, China
Correspondence to: Zhengping Liu, email: liuzphlk81@outlook.com 
Xiaoling Guo, email: fsguoxl@163.com
Keywords: non-syndromic orofacial clefts; perinatal infants; prevalence; meta-analysis; China
Received: June 27, 2017    Accepted: December 05, 2017    Published: January 13, 2018
Copyright: Fan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 
3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
ABSTRACT
Non-syndromic orofacial clefts (NSOFC), which include cleft lip and palate 
(CLP), cleft lip only (CLO), and cleft palate only (CPO), contains a range of disorders 
affecting the lips and oral cavity. No systematic review and meta-analysis has been 
carried out to synthesize the prevalence of NSOFC in Chinese perinatal infants. We 
aimed to quantify and understand the variation of prevalence national and regional 
levels. Four English databases and four Chinese databases were searched using a 
comprehensive search strategy from inception to April 2017. The random effect model 
was used for this meta-analysis. To determine the sources of heterogeneity, subgroup 
analyses and meta-regression were conducted based on different categories. The 
protocol has been pre-registered in the PROSPERO, number CRD42017062293. 110 
studies, including 15,094,978 Chinese perinatal infants, were eligible for inclusion. 
The pooled prevalence rate for NSOFC was 1.67‰ (95% CI 1.53–1.82), varying with 
provinces. The pooled prevalence estimate was 0.56‰ (0.50–0.63) for CLO, 0.82‰ 
(0.73–0.90) for CLP, and 0.27‰ (0.24–0.30) for CPO. Significant associations were 
found between overall prevalence estimates and survey year and study region. The 
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prevalence of NSOFC was severe in Chinese perinatal infants, varying with provinces. 
The results will serve as a baseline for future assessment of the overall effectiveness 
of NSOFC control, and will also support and inform health policy for planning and 
helping health debates.
INTRODUCTION
Non-syndromic orofacial clefts (NSOFC), which 
include cleft lip and palate (CLP), cleft lip only (CLO), 
and cleft palate only (CPO), contains a range of disorders 
affecting the lips and oral cavity [1, 2]. The etiology 
and pathogenesis of NSOFC remain largely unknown 
and involve both genetic and environmental factors 
contributing to the phenotype [3–5]. It has been shown 
that these congenital disorders have a significant negative 
impact on audition, speech, appearance and psychology, 
which could affect the individuals and their families [6]. 
Theses impacts can lead to considerable adverse health 
outcomes and enormous socioeconomic burden [7]. The 
global average prevalence of NSOFC was approximately 
1.7‰ in live birth babies [1]. However, the prevalence of 
NSOFC varies broadly with the difference of ethnicities 
and geographical positions, and populations of African 
ancestry having the lowest rates while groups of 
Amerindian and Asian ancestry possessing the largest 
[5]. One previous systematic review and meta-analysis 
emerged in the scientific literature found that the birth 
prevalence of orofacial clefts was 1.38 per 1000 birth in 
low- and middle-income countries [8].
China is the biggest developing country and has the 
largest population in the world. Since mid-1980s, congenital 
anomalies surveillance systems have been progressively 
established in hospitals in mainland China [9]. After 30-year 
effort, all the infants (including live births, stillbirths, abortion 
or dead fetus) during perinatal period (between 28 gestation 
weeks and 7 days after birth) will be registered in hospitals. 
Individual studies have demonstrated that NSOFC (including 
CLO, CLP, and CPO) is the most common congenital 
disorders in Chinese perinatal infants [10–12]. Nevertheless, 
estimates of the prevalence of NSOFC among perinatal 
infants vary across studies from 0.32‰ to 4.70‰ [13, 14].
Reliable estimate of prevalence is important for 
informing efforts to prevent, treat, and identify causes 
of this disorder among perinatal infants. Hence, the 
relevant studies are warranted. Meanwhile, many 
factors, such as survey year, hospital level, sample size, 
and geographical locations could easily influence the 
results. We, therefore, aimed to address this research 
gap by means of a systematic review and meta-analysis 
of published studies. To the best of our knowledge, this 
is the first study to determine the prevalence and the 
characteristics of NSOFC (including CLO, CLP, and CPO) 
in Chinese perinatal infants. The results will be essential 
for policymakers and health professionals aware of this 
influential congenital disorder in Chinese perinatal infants 
and will be useful for the planning of health services.
RESULTS
Characteristics of study
In total, 11967 studies were identified using the 
initial literature search. The search results were as follows: 
PubMed (n = 390), Elsevier Science Direct (n = 6868), 
Web of Science (n = 578), Cochrane Library (n = 40), 
CBM (n = 764), CNKI (n = 1133), Chongqing VIP (n 
= 895), and WanFang (n = 1299). After removing 4032 
duplicates and 7383 apparently irrelevant citations by title 
and abstract review, 552 potentially eligible articles and 
were reviewed in full-text level. After carefully reading, 
442 of them were excluded for various reasons (including 
7 duplicates, 25 review articles, 29 diagnostic criteria 
different, 41 not perinatal infants, 47 community-based 
survey and 293 accurate data not reported). Finally, a total 
of 110 articles, including 138 survey researches, met the 
inclusion criteria in the final meta-analysis (Figure 1).
Detailed characteristics of each included study 
were shown in Supplementary Table 1. Twenty-nine 
studies with regarding to the prevalence of NSOFC in 
Chinese perinatal infants were implemented in East China 
(4 in Anhui, 2 in Fujian, 5 in Jiangsu, 3 in Jiangxi, 6 in 
Shandong, 3 in Shanghai, 6 in Zhejiang), 12 in North 
China (2 in Beijing, 2 in Hebei, 2 in Inner Mongolia, 3 in 
Shanxi, 3 in Tianjin), 16 in Northwest China (2 in Gansu, 
6 in Ningxia, 2 in Qinghai, 3 in Shaanxi, 3 in Xinjiang), 
16 in South China (11 in Guangdong, 4 in Guangxi, 1 in 
Hainan), 13 in Central China (3 in Henan, 3 in Hubei, 7 
in Hunan), 10 in Northeast China (2 in Heilongjiang, 4 
in Jilin, 4 in Liaoning), and 10 in Southwest China (1 in 
Chongqing, 2 in Guizhou, 2 in Sichuan, 1 in Tibet, 4 in 
Yunnan).
A total of 110 articles including 15,094,978 Chinese 
perinatal infants with a mean number of 137,227 were 
included. The sample sizes of the included articles ranged 
from 4192 to 1395155. The articles were published from 
1989 to 2017. Of the 110 eligible articles, the mean NOS 
score was 7.83, with 24 studies scored 9, 45 studies scored 
8, 39 studies scored 7, and 2 studies scored 6.
Meta-analysis
Seventy-eight articles, which were constituted of 
106 surveys, have reported the prevalence of NSOFC 
based on the data of 9476601 Chinese perinatal infants. 
The prevalence of NSOFC varied from 0.32‰ (95% 
confidence interval [CI], 0.28–0.35) [13] to 4.70‰ 
(95% CI, 3.45–5.95) [14]. The meta-analysis revealed 
significantly high heterogeneity across studies (I2 = 
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97.3%, p < 0.001). Using a random effects model, the 
pooled point prevalence of NSOFC was 1.67‰ (95% CI, 
1.53–1.82; I2 = 97.3%). Sensitivity analysis showed that 
the pooled prevalence was between 1.66‰ (95% CI, 1.51–
1.80) (after excluding Zhang JX et al. [14]) and 1.69‰ 
(95% CI, 1.54 – 1.83) (after excluding Yi YT et al. [15]). 
These similar results indicated that no individual study 
affected the overall pooled estimate of the meta-analysis. 
As shown in Supplemenatry Figure 1, although the funnel 
plot was slightly asymmetrical, no publication bias was 
found according to the results of both Egger’s test (t = 
−0.21, p = 0.834) and Begg’s test (z = 1.94, p = 0.053).
Subgroup analyses
We further examined pooled prevalence according 
to the subtypes of CLO, CLP, and CPO. For the 92 studies 
that included 7511 perinatal infants with CLO, the pooled 
prevalence was 0.56‰ (95% CI, 0.50 – 0.63). Another 
84 studies that included 8463 perinatal infants with CLP 
gave a pooled prevalence of 0.82‰ (95% CI, 0.73 – 0.90), 
and a pooled prevalence of 0.27‰ (95% CI, 0.24 – 0.30) 
were calculated from 42 studies, including 1959 perinatal 
infants with CPO.
To further characterize the potential impact to the 
pooled prevalence from the different sample sizes of the 
included studies, meta-analysis was stratified by sample 
size. Pooled prevalence estimates were: 0.99‰ (95% CI, 
0.57–1.43) for sample sizes more than 1000000 individuals; 
1.55‰ (95% CI, 1.34–1.76) for sample sizes between 
100000 and 1000000; 1.67‰ (95% CI, 1.56–1.78) for 
sample sizes between 10000 and 100000; and 2.17‰ (95% 
CI, 1.62–2.72) for sample sizes less than 10000 (Figure 2).
According to hospital level, the results were 
classified as follows: primary hospital (1.72‰, 95% CI, 
1.46–1.97), secondary hospital (1.57‰, 95% CI, 1.42–
1.72), and tertiary hospital (1.72‰, 95% CI, 1.47–1.97). 
Prevalence of NSOFC by year groups of before 2000, 
2000–2009, and 2010 to date were 1.78‰ (95% CI, 1.66 
–1.91), 1.66‰ (95% CI, 1.44–1.89), and 1.40‰ (95% 
CI, 1.17–1.63), respectively (Figure 2). Although there 
were no significant time trends, the trend line showed 
that there was a progressively decreasing of prevalence 
over the year. The decreasing was also reflected in 
each hospital level, including primary-, secondary- and 
tertiary-hospital (Figure 3). In subgroup analysis based 
on socioeconomic status, the prevalence was highest in 
low level socioeconomic condition (1.95‰, 95% CI, 
1.82–2.09), followed by middle level (1.65‰, 95% CI, 
1.52–1.78), and high level (1.46‰, 95% CI, 1.24–1.68).
Regarding different study location, fifty-nine and 
forty-seven studies offered the prevalence of NSOFC 
in inland and coastal area, respectively. The prevalence 
was 1.79‰ (95% CI, 1.67–1.90) in inland area perinatal 
infants, and coastal area perinatal infants seemed to 
have a lower prevalence with an estimation of 1.49‰ 
(95% CI, 1.27–1.71). Among study regions, the highest 
prevalence was 2.19‰ (95% CI, 1.99–2.40) in northwest 
China, followed by southwest China (1.97‰ (95% CI, 
1.69–2.56)), then north China (1.72‰ (95% CI, 1.46–
1.98)), south China (1.65‰ (95% CI, 1.21–2.09)), central 
China (1.52‰ (95% CI, 1.33–1.72)), and northeast 
China (1.47‰ (95% CI, 1.20–1.74)), and east China had 
the lowest prevalence (1.39‰ (95% CI, 1.23–1.56)). 
Further subgroup analysis found that the highest pooled 
prevalence of NSOFC among perinatal infants was 4.70‰ 
in Hainan, and the lowest was 0.98‰ in Shandong. There 
were significant varied with the provinces (Figure 4).  
Sample size, survey year, hospital level, and study 
region were entered into the meta-regression, which 
yielded a significant model (F = 4.11, p = 0.0040) that 
explained 13.59% of the variance. Meanwhile, we found 
that survey year and study region were significantly 
associated with heterogeneity in this meta-analysis. The 
t-values were 2.27 and -2.58; and the p-values were 0.025 
and 0.011 for the two variables, respectively.
DISCUSSION
To the best of our knowledge, this is the first 
systematic review and meta-analysis based on Chinese 
hospital-based congenital anomalies surveillance systems 
to determine the national prevalence and its characteristics 
of non-syndromic orofacial clefts (NSOFC). The present 
systematic review included 110 articles, involving 
15,094,978 Chinese perinatal infants in all 31 provinces, 
to demonstrate the prevalence of NSOFC and its 
subgroups, cleft lip only (CLO), cleft lip and palate (CLP), 
and cleft palate only (CPO). The prevalence of NSOFC 
was 1.67‰ (95% CI, 1.53–1.82). Further results showed 
that prevalence estimates for CLP was highest (0.82‰), 
followed by CLO (0.56‰) and CPO (0.27‰). Given 
the approximate 2016 population estimates of 17 million 
perinatal infants [16], this rate amounts to 28390 suffers 
of NSOFC annually in China. 
NSOFC is one of the most common congenital 
birth defects in perinatal infants and imposes a substantial 
physical and financial burden on affected individuals 
and families [3, 6]. Fetuses with NSOFC usually could 
be identified by ultrasound. Prenatal transabdominal 
sonographic could detect the defects during the second 
trimester (14–28 weeks) of pregnancy [17]. The detection 
rate can reach 100% [18], however, the accuracy is 
highly variable and dependent on the experience of the 
sonographer, gestational age, the types and fetal position 
[19]. The sex ratio (male : female) was reported about 
2:1 in white population [1] and about 1.25:1 in Chinese 
population [20]. About seven in ten (68%) NSOFC infants 
were suffered from malnutrition, which is also a major 
cause of the high mortality of infants [21].
NSOFC is generally classified as CLP, CLO, or 
CPO. Because CPO is less noticeable externally, the 
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prevalence of CPO might underestimate in perinatal 
infants in initial survey studies. Findings from this study 
showed that the prevalence of CPO accounted for only a 
half of CLO and one third of CLP in Chinese perinatal 
infants. Meanwhile, previous studies [6, 8] were also 
found CLP high compared to CLO, which were similar 
to our result. A possible explanation for this difference 
is that cleft hard palate is often accompanied by a cleft 
lip [1]. Furthermore, difficulties in identifying perinatal 
infants with not obvious cleft lip are likely to lead to 
underascertainment at the beginning of the studies [22].
We found that the prevalence of NSOFC reduced 
gradually from 2.17 to 0.99 per 1000 perinatal infants with 
the increasing of sample size, which plays an important 
role in epidemiology surveys. Small sample sizes are more 
likely to lead to instable results, especially in the calculation 
of prevalence in rare diseases [23]. Systematic review and 
meta-analysis provides a scientific and logical method to 
Figure 1: Flowchart of study selection.
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synthesize epidemiological data, and it could enhance the 
statistical power as well as draw a more reliable conclusion 
when compared with single studies [24].
A recent systematic review showed that the overall 
prevalence of orofacial clefts was 1.40‰ in Chinese live 
births [25]. Because few included studies reported relevant 
data, the study was not estimated the prevalence of cleft 
types (CLO, CLP, and CPO). And more importantly, 
Mossey P has reported that stillbirths have higher prevalence 
of orofacial clefts than live births [26]. Thus, the prevalence 
rate of orofacial clefts in live births is generally lower than 
in perinatal infants. Our results further confirmed Mossey 
P’s findings. Because of the difference in participants, the 
results, including region, socioeconomic status, sample size, 
will be different between the two articles.
Genetic and epidemiological studies have clarified 
that the etiology of NSOFC is involving genetic and 
environmental risk factors [27–30]. Findings of genome-
wide and genome-wide meta-analyses have suggested 
various loci could have a causal role in NSOFC, including 
1p22.1: rs560426, 1q32.2: rs861020, 8q24: rs987525, 
10q25: rs7078160, and 13q31.1: rs8001641 [28, 29]. 
About 30% NSOFC cases can be contributed to these 
various locus [1, 28, 29]. In addition, epidemiological 
and experimental data suggested that poor nutrition, 
maternal tobacco smoking, maternal alcohol use, viral 
infection, and glucocorticoid exposure were risk factors 
for NSOFC [31–33]. Maternal smoking during pregnancy 
has been associated with increased risk of NSOFC, with a 
population-attributable risk as high as 20% [34, 35].
Figure 2: Results of subgroup analysis for the pooled prevalence of NSOFC in Chinese perinatal infants.
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Stratified by time spans, the highest prevalence 
of NSOFC was observed before 2000, and the lowest in 
2010 to date. Although the results were not significantly 
different, it seems that there is a decreasing trend of 
prevalence with time. After further study, the trend line 
also showed there was a progressively decreasing of 
prevalence over the year. On one hand, the high prevalence 
appeared before 2009 might be partly explained by 
complete ascertainment through the registry and improved 
prenatal detection [36]. On the other hand, the decreasing 
trend after 2010 might be attributed that the government 
refocused the importance of the primary prevention for 
women at childbearing age [37]. Most cities [38–40] 
have switched from prenatal care to preconceptional or 
periconceptional care through the Local Family Planning 
System and Maternal and Child Health Care System in 
recent years. In addition, prenatal diagnostic techniques, 
including fetal ultrasound, fetal echocardiography, and 
karyotyping following amniocentesis and chorionic villus 
sampling have been available to diagnose severe structural 
defects before early second trimester (usually before 22 
gestational weeks) [41], and virtually all mothers who 
carry a fetus affected by a severe malformation would 
choose elective termination [42].
China is a vast, multiracial country, and in this 
study we found significant differences in the prevalence 
of NSOFC in perinatal infants by territories (inland vs 
coastal, and between regions and provinces). Inland 
perinatal infants have a higher prevalence compared with 
that of coastal area, and prevalence varied substantially 
among the 7 regions and 31 provinces. The prevalence 
of provinces spans from 0.98 to 4.70 per 1000 perinatal 
infants. The highest reported rates were in Hainan, 
Chongqing, and Qinghai, with prevalence rates of 4.70, 
3.17, and 3.00 per 1000 perinatal infants, respectively. 
The lowest reported rates were in Shandong, Fujian, and 
Liaoning, with prevalence of 0.98, 1.06, and 1.29 per 1000 
perinatal infants, respectively. It is likely that many factors 
could contribute to this geographic difference, such as 
environmental pollution, economic status, health service 
status, and diagnostic level [11].
Most of the minorities are concentrated in 
northwest and southwest developing provinces in China 
[43]. Compared to east developed provinces, there are 
some differences in their genetics and lifestyle [44, 45]. 
Meanwhile, prenatal diagnostic techniques vary greatly 
among provinces and hospitals in China. The developed 
provinces have made the greatest efforts in prenatal 
screening and diagnosis and mothers would choose 
elective termination before 22 gestational weeks when 
they found a fetus affected by a severe malformation 
[42]. Meanwhile, most coastal cities attached importance 
to the primary prevention in childbearing age women, 
which could reduce the occurrence of birth defects [39]. 
The above reasons can be partially explained why there 
is the different prevalence based on different regions. To 
reduce the incidence of NSOFC, preconception care and 
antenatal screening should be promoted in every women 
of reproductive age.
There are many strengths in our systematic review 
and meta-analysis. No systematic review and meta-
analysis has been performed to synthesize the prevalence 
of NSOFC in Chinese perinatal infants. Our study is 
the first to adhere to PRISMA guidelines to quantify 
Figure 3: Trend lines of the prevalence of NSOFC over the year (x axes is the survey year, y axes is prevalence (per 
1000)). (A) all of Chinese perinatal infants, (B) by primary hospital, (C) by secondary hospital, (D) by tertiary hospital.
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prevalence estimates derived from a comprehensive search 
strategy. It has a relatively large number of perinatal 
infants which including 15,094,978 across all 31 provinces 
in mainland China, and this allows us to get a stable result. 
Meanwhile, overall quality of the included studies was 
acceptable, publication bias tests did not show potential 
risk, and sensitivity analysis was not substantially altered.
Despite the strengths of this study, several 
limitations need to be considered in interpreting with 
future research. On one hand, like other similar prevalence 
meta-analyses [46–49], heterogeneity usually existed, and 
was not fully resolved by subgroup and regression model, 
although survey year and study region could explain a part 
of its heterogeneity. On the other hand, it should be noted 
that due to mild disorders, especially in CPO, undiagnosed 
in utero or lack of external visibility at birth may be 
underestimate the true prevalence. Meanwhile, the sources 
of data were all captured from hospital-based surveillance 
systems, which could also underestimate the prevalence 
compared with population-based survey. In addition, 
because of the limited information in included studies, this 
prevalence meta-analysis could not provide more detailed 
results, such as age of infants when disease was diagnosed, 
sex ratio of infants diagnosed with NSOFC, and trend 
lines of prevalence in each province.
In this systematic review, the pooled estimate of 
the prevalence of NSOFC was 1.67 per 1000 in Chinese 
perinatal infants, varying with provinces. The result will 
serve as a baseline for future assessment of the overall 
effectiveness of the NSOFC control in China, and will also 
could support and inform health policy for planning and 
helping health debates.
MATERIALS AND METHODS
Protocol and registration
Similar as our previous studies [50–52], this meta-
analysis was also strictly performed according to the 
guidelines in the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) statement 
(Supplementary Table 2) [53]. The protocol for this 
systematic review was pre-registered in the PROSPERO 
International Prospective Register of systematic reviews 
(http://www.crd.york.ac.uk/PROSPERO/), and the 
registration number is CRD42017062293.
Figure 4: Map of the prevalence of NSOFC in Mainland Chinese perinatal infants (not including Hong Kong, Macao, 
and Taiwan). The pooled prevalence of NSOFC among perinatal infants was 4.70‰ in Hainan, followed by 3.17‰ in Chongqing, 3.00‰ 
in Qinghai, 2.84‰ in Tibet, 2.46‰ in Gansu, 2.27‰ in Guizhou, 2.18‰ in Ningxia, 2.11‰ in Shaanxi, 1.97‰ in Shanxi and Sichuan, 
1.94‰ in Henan, 1.80‰ in Xinjiang, 1.78‰ in Hebei, 1.77‰ in Shanghai, 1.74‰ in Tianjin, 1.72‰ in Guangxi, 1.65‰ in Anhui, 1.62‰ 
in Jilin, 1.57‰ in Zhejiang, 1.55‰ in Jiangxi, 1.54‰ in Inner Mongolia, 1.53‰ in Yunnan, 1.51‰ in Heilongjiang, 1.45‰ in Hunan, 
1.44‰ in Guangdong, 1.44‰ in Hubei, 1.37‰ in Jiangsu, 1.35‰ in Beijing, 1.29‰ in Liaoning, 1.06‰ in Fujian, and the lowest is 0.98‰ 
in Shandong.
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Search strategy
Data for this meta-analysis was comprehensively 
identified by searching four English databases (PubMed, 
Elsevier Science Direct, Web of Science, Cochrane 
Library) and four Chinese databases (Chinese Biological 
Medical Literature database (CBM), Chinese National 
Knowledge Infrastructure (CNKI), Chongqing VIP (VIP), 
WanFang) from inception to April 2017. Search strategy 
was listed as follows: (“birth defect” OR “orofacial clefts” 
OR “cleft lip” OR “cleft lip and palate” OR “cleft palate”) 
AND (“prevalence” OR “incidence” OR “epidemiology” 
OR “Survey”) AND (“China” OR “Chinese”). In addition, 
snowball searching of reference lists was also conducted 
to find further relevant articles.
Language was restricted to either Chinese or English. 
Two researchers (L Liu and G Tian) independently reviewed 
all titles and abstracts. The complete relevant articles were 
downloaded for further screening. If the same data was 
reported in more than one publication, only the paper with 
a better quality was included. Any uncertainty was settled 
by discussion with the third participant (D Fan). In addition, 
we performed a further search by perusing the references 
of review articles and e-mailing the authors for full-text 
articles to include all available data in this meta-analysis.
Inclusion and exclusion criteria
Articles fulfilling the following criteria were 
considered eligible for inclusion: 1) cross-sectional 
studies examining prevalence of NSOFC (including CLO, 
CLP, and/or CPO) in perinatal infants (between 28 weeks 
of gestation and 7 days after birth) in mainland China 
(not including Hong Kong, Taiwan, and Macao); 2) the 
diagnosis was based on the Chinese national criteria of 
birth defects [9]; 3) sample sizes from hospital-based 
survey; 4) publications in full text either written in English 
or in Chinese. Studies conducted in specific populations 
(e.g., children, adolescents, and the elderly) or special 
settings (e.g. community-based, population-based) and 
studies used census sampling were excluded.
Data extraction
The available data extraction was independently 
performed by two researchers using a standardized form, 
and the disagreement was resolved through discussion. 
The key data extraction sheet included: first author, year of 
publication, year of the study conducted, province where 
the survey was conducted, number of perinatal infants, 
number of NSOFC (CLO, CLP, and/or CPO).
Quality assessment
In line with other and our previously studies [54, 
55], two researchers (SZ Wu and W Wang) independently 
assessed the risk of bias and methodological quality of 
each study using the Newcastle-Ottawa Score (NOS) for 
evaluating the quality of observational epidemiological 
studies [56].
Statistical analysis
In this meta-analysis, all statistical analyses were 
undertaken with STATA software, Version 12.0 (Stata 
Corporation, College Station, Texas, USA). Cochran’s 
Q statistic and I2 index were calculated to assess the 
heterogeneity of the prevalence across studies. A p < 
0.05 or the I2 statistic > 50% indicated heterogeneity in 
the effect size [57]. Due to heterogeneity across studies, 
a random effect model was used for this meta-analysis 
[58]. To determine the sources of heterogeneity, subgroup 
analyses and meta-regression were conducted based 
on different categories: sample size (< 10000, 10000 
- 100000, 100000 – 1000000, and > 1000000), year 
of data collection (before 2000, 2000–2009, and after 
2010), hospital level (primary, secondary, and tertiary), 
socioeconomic status [59], study location (inland and 
coastal), and study region (east, north, northwest, 
northeast, southwest, central, and south). Moreover, 
in order to more clearly display area distribution, the 
prevalence of each province was also calculated. Maps 
were drawn using ArcMap version 10.2 (Environmental 
Systems Research Institute, Redlands, CA). To test 
the robustness of the result on the overall prevalence 
estimates, sensitivity analysis was performed by serially 
excluding each included studies. Publication bias was 
estimated by testing for funnel plot asymmetry and using 
Egger’s and Begg’s test. All p-values were two-sided, 
and p < 0.05 was regarded statistically significant.
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